Inhibrx Biosciences INBX
NASDAQ INBX
$97.93 -2.15 (-2.15%)
At close: Oct 1, 2026 · 4:00 PM EDT

Inhibrx Biosciences (INBX) Non Operating Income (2023 - 2026)

Updated

Inhibrx Biosciences' Non Operating Income came in at -$4.5 million for Q2 2026, compared with -$1.26 million a year earlier.

Analysis

Inhibrx Biosciences (INBX) Non Operating Income (2023 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Inhibrx Biosciences reported Non Operating Income of -$9.12 million; for FY2025, it came in at -$5.03 million.

  • Going back by year, Non Operating Income was $2.02 billion in FY2024 and -$20.5 million in FY2023.
  • The Q2 2026 figure represents the lowest quarterly Non Operating Income since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Inhibrx Biosciences 1.47 Bn 1.47 Bn - -4.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.50 Mn
Dec 31, 2025 -1.91 Mn
Sep 30, 2025 -1.44 Mn
Jun 30, 2025 -1.26 Mn
Mar 31, 2025 -410,000.00
Dec 31, 2024 2.06 Mn
Sep 30, 2024 2.93 Mn
Jun 30, 2024 2.02 Bn
Mar 31, 2024 -4.89 Mn
Dec 31, 2023 -3.69 Mn
Sep 30, 2023 -5.96 Mn
Jun 30, 2023 -5.71 Mn
API Access

Inhibrx Biosciences Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=INBX&period=max&api_key=YOUR_API_KEY